DXR Soars On Big Volume, RXII Gets Attention, Busy Q2 Awaits SNDX

Daxor Corp. gained 56% on Wednesday, following new data from its study showing that patient care individualized by its Precision Blood Volume Analysis (BVA) reduces heart failure readmissions by 56% and mortality by over 80%.

from RTT - Biotech http://ift.tt/2FRhXOb
via IFTTT